Terms: = Uterine cancer AND FES, FPS, 2242, ENSG00000182511, P07332 AND Diagnosis
11 results:
1. PET Imaging of Estrogen Receptors for Gynecological Tumors.
Tsujikawa T; Makino A; Mori T; Tsuyoshi H; Kiyono Y; Yoshida Y; Okazawa H
Clin Nucl Med; 2022 Jul; 47(7):e481-e488. PubMed ID: 35675139
[TBL] [Abstract] [Full Text] [Related]
2. Contrast-Enhancing Snapshot Narrow-Band Imaging Method for Real-Time Computer-Aided Cervical cancer Screening.
Yi D; Kong L; Zhao Y
J Digit Imaging; 2020 Feb; 33(1):211-220. PubMed ID: 31069586
[TBL] [Abstract] [Full Text] [Related]
3. A Novel Approach of Mathematical Theory of Shape and Neuro-Fuzzy Based Diagnostic Analysis of Cervical cancer.
Kar S; Majumder DD
Pathol Oncol Res; 2019 Apr; 25(2):777-790. PubMed ID: 30729412
[TBL] [Abstract] [Full Text] [Related]
4. 18F-fes and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.
Zhao Z; Yoshida Y; Kurokawa T; Kiyono Y; Mori T; Okazawa H
J Nucl Med; 2013 Apr; 54(4):499-506. PubMed ID: 23471314
[TBL] [Abstract] [Full Text] [Related]
5. Fluorescence spectra of blood and urine for cervical cancer detection.
Masilamani V; Alsalhi MS; Vijmasi T; Govindarajan K; Rathan Rai R; Atif M; Prasad S; Aldwayyan AS
J Biomed Opt; 2012 Sep; 17(9):98001-1. PubMed ID: 23085927
[TBL] [Abstract] [Full Text] [Related]
6. Additional value of 16α-[18F]fluoro-17β-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET.
Yoshida Y; Kiyono Y; Tsujikawa T; Kurokawa T; Okazawa H; Kotsuji F
Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1824-31. PubMed ID: 21656049
[TBL] [Abstract] [Full Text] [Related]
7. Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET.
Tsujikawa T; Yoshida Y; Kudo T; Kiyono Y; Kurokawa T; Kobayashi M; Tsuchida T; Fujibayashi Y; Kotsuji F; Okazawa H
J Nucl Med; 2009 Oct; 50(10):1598-604. PubMed ID: 19759112
[TBL] [Abstract] [Full Text] [Related]
8. uterine tumors: pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET--initial experience.
Tsujikawa T; Yoshida Y; Mori T; Kurokawa T; Fujibayashi Y; Kotsuji F; Okazawa H
Radiology; 2008 Aug; 248(2):599-605. PubMed ID: 18539894
[TBL] [Abstract] [Full Text] [Related]
9. [Role of cervical smear in the diagnosis of cervical cancer in fes-Boulemane region of Morocco].
Bennis S; Meniar S; Amarti A; Bijou A
East Mediterr Health J; 2007; 13(5):1153-9. PubMed ID: 18290409
[TBL] [Abstract] [Full Text] [Related]
10. The positron emission tomography with F18 17beta-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer.
Yoshida Y; Kurokawa T; Sawamura Y; Shinagawa A; Okazawa H; Fujibayashi Y; Kotsuji F
Gynecol Oncol; 2007 Mar; 104(3):764-6. PubMed ID: 17156828
[TBL] [Abstract] [Full Text] [Related]
11. Comparative benefits and limitations of 18F-FDG PET and CT-MRI in documented or suspected recurrent cervical cancer.
Yen TC; Lai CH; Ma SY; Huang KG; Huang HJ; Hong JH; Hsueh S; Lin WJ; Ng KK; Chang TC
Eur J Nucl Med Mol Imaging; 2006 Dec; 33(12):1399-407. PubMed ID: 16847653
[TBL] [Abstract] [Full Text] [Related]